Essential Partners’s Edwards Lifesciences EW Stock Holding History

Essential Partners’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$127K	Hold	1,475	–	–	0.06%	356
2026 Q2	$133K	Sell	1,475 -2,863	-66%	-$240K	0.06%	340
2026 Q1	$347K	Sell	4,338 -281	-6%	-$23.2K	0.12%	196
2025 Q4	$394K	Buy	4,619 +514	+13%	+$42.2K	0.12%	215
2025 Q3	$319K	Buy	4,105 +2,054	+100%	+$160K	0.11%	238
2025 Q2	$160K	Buy	+2,051	New	+$153K	0.06%	301

Other funds holding EW

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Ninety One North America New York $2.13B AUM 8.8% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Essential Partners's EW Position: Q3 2026 in Review

Essential Partners held its Edwards Lifesciences (EW) position steady in Q3 2026 at 1,475 shares worth $127K. The position accounts for 0.06% of the portfolio, ranked #356.

Essential Partners first reported a position in EW in Q2 2025 and has held it in 6 quarters since. The position peaked at $394K in Q4 2025. 278 funds tracked by Wall St. Rank hold EW as of Q3 2026.

Essential Partners held 1,475 shares of Edwards Lifesciences worth $127K as of Q3 2026.
Essential Partners left its Edwards Lifesciences share count unchanged in Q3 2026.
Edwards Lifesciences made up 0.06% of Essential Partners's portfolio in Q3 2026, its #356 holding.
Essential Partners first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 6 quarters since.
Essential Partners's Edwards Lifesciences position peaked at $394K in Q4 2025.
278 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.